Esketamine: a glimmer of hope in treatment-resistant depression
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00406-019-01084-z.pdf
Reference58 articles.
1. World Health Organization (2017) Depression and other common mental disorders. Inst Health Natl 1:1–22
2. Stassen HH, Angst J (1998) Delayed onset of action of antidepressants. CNS Drugs 9(3):177–184
3. Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA (2016) The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 85(5):270–288
4. Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC et al (2018) Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression. JAMA Psychiatry 75(2):139
5. Morrison RL, Fedgchin M, Singh J, Van Gerven J, Zuiker R, Lim KS et al (2018) Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study. Psychopharmacology 235(4):1107–1119
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The effect and mechanism of low-dose esketamine in neuropathic pain-related depression-like behavior in rats;Brain Research;2024-11
2. Assessing suicide risk in chronic pain management: a narrative review across drug classes;Expert Opinion on Drug Safety;2024-08-19
3. Targeting NMDA receptors with an antagonist is a promising therapeutic strategy for treating neurological disorders;Behavioural Brain Research;2024-08
4. Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov;Translational Psychiatry;2024-07-31
5. Effect of esketamine on haemodynamic fluctuations in patients undergoing hysteroscopic surgery: A prospective, double‐blind randomized clinical trial;British Journal of Clinical Pharmacology;2024-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3